1.59
1.27%
0.02
Finanzdaten der Werewolf Therapeutics Inc-Aktie (HOWL)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
50.57%
0.742
|
1.501 | 5.897 | 8.081 | 4.464 |
Operating Expenses
|
23.79%
17.90
|
14.46 | 15.15 | 14.15 | 16.69 |
Interest Income/Expense |
1.003
|
- | - | - | - |
Benefits Costs and Expenses |
25.41%
16.93
|
13.50 | 14.18 | 13.18 | 16.45 |
Costs And Expenses |
23.79%
17.90
|
14.46 | 15.15 | 14.15 | 16.69 |
Operating Income/Loss |
32.40%
-17.16
|
-12.96 | -9.251 | -6.067 | -12.22 |
Nonoperating Income/Loss |
1.04%
0.969
|
0.959 | 0.966 | 0.969 | 0.241 |
Income/Loss From Continuing Operations Before Tax |
34.91%
-16.19
|
-12.00 | -8.285 | -5.098 | -11.98 |
Income/Loss From Continuing Operations After Tax |
34.91%
-16.19
|
-12.00 | -8.285 | -5.098 | -11.98 |
Net Income/Loss
|
34.91%
-16.19
|
-12.00 | -8.285 | -5.098 | -11.98 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
13,254%
41.61
|
0.3116 | 35.65 | 35.56 | 34.78 |
Diluted Average Shares |
13,254%
41.61
|
0.3116 | 35.65 | 35.56 | 34.78 |
Basic Earnings Per Share |
18.18%
-0.39
|
-0.33 | -0.23 | -0.14 | -0.34 |
Diluted Earnings Per Share |
18.18%
-0.39
|
-0.33 | -0.23 | -0.14 | -0.34 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):